Behbehani Gregory K
Division of Hematology, The Ohio State University and James Cancer Hospital, B305 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.
Clin Lab Med. 2017 Dec;37(4):945-964. doi: 10.1016/j.cll.2017.07.010.
Mass cytometry is a novel technology similar to flow cytometry in which antibodies are tagged with heavy metal molecules rather than fluorophores and then detected with time-of-flight mass spectrometry. This enables measurement of up to 50 simultaneous parameters with no autofluorescent background and little or no spillover or required compensation. Mass cytometry has tremendous potential for the analysis of highly complex clinical samples for the diagnosis and monitoring of malignant and autoimmune disorders. The technology also presents several unique challenges for clinical use and will require new approaches to analyze the large amounts of data generated.
质谱流式细胞术是一种类似于流式细胞术的新技术,其中抗体用重金属分子而非荧光团标记,然后用时序飞行质谱进行检测。这使得能够在没有自发荧光背景、几乎没有或不存在信号重叠或无需补偿的情况下同时测量多达50个参数。质谱流式细胞术在分析高度复杂的临床样本以诊断和监测恶性及自身免疫性疾病方面具有巨大潜力。该技术在临床应用中也带来了一些独特的挑战,并且需要新的方法来分析所产生的大量数据。